Last updated: 2026-09-02 · 5 min read

Medical-Grade Resin Selection — What Are the Biocompatibility, Sterilization and Regulatory Constraints for Injection Molded Parts?

Medical-grade resins must meet biocompatibility requirements (ISO 10993-5 for cytotoxicity, ISO 10993-10 for sensitization), withstand the specified sterilization method (EtO, gamma, e-beam or autoclave), and be processed in a controlled environment — but the resin selection is only one part of the regulatory pathway, which is the responsibility of the device manufacturer, not the mold maker. The mold maker produces the part to the specified resin and process; the device manufacturer validates the biocompatibility, sterilization and regulatory compliance of the finished device.

Shrinkage — The dimensional reduction from mold cavity to cooled part. Amorphous resins: 0.4–0.7% (uniform). Semi-crystalline: 1.0–2.5% (directional). Mold makers apply shrinkage factor when machining cavity. Actual shrinkage varies with wall thickness, gate location and packing pressure. See also related guide.

Key Facts

  • Common medical-grade resins: PC (polycarbonate) for transparent housings and connectors; PP (polypropylene) for autoclavable containers and syringe barrels; ABS for non-transparent device housings; PEEK for implantable components and surgical instruments; silicone (LSR) for seals, gaskets and flexible components.
  • Sterilization compatibility: PC and ABS withstand EtO (ethylene oxide) but not autoclave (121°C); PP withstands autoclave and gamma; PEEK withstands all methods (autoclave, EtO, gamma, e-beam). The resin must be selected for the sterilization method specified in the device’s regulatory submission.
  • Biocompatibility testing is performed on the finished device — not the raw resin. The resin supplier provides biocompatibility data for the resin grade, but the device manufacturer must validate that the finished device (including processing aids, colorants and surface treatments) meets the biocompatibility requirements.

    • Shrinkage — The dimensional reduction from mold cavity to cooled part. Amorphous resins: 0.4–0.7% (uniform). Semi-crystalline: 1.0–2.5% (directional). Mold makers apply shrinkage factor when machining cavity. Actual shrinkage varies with wall thickness, gate location and packing pressure. The related guide covers adjacent topics.

    Resin Selection by Application and Sterilization

    Resin Application Sterilization
    PC (polycarbonate) Transparent housings, connectors, fluid paths EtO, gamma (limited)
    PP (polypropylene) Syringe barrels, containers, caps Autoclave, EtO, gamma
    ABS Device housings, non-transparent components EtO only
    PEEK Implantable components, surgical instruments All methods (autoclave, EtO, gamma, e-beam)
    Silicone (LSR) Seals, gaskets, flexible components Autoclave, EtO, gamma

    Constraints and Limitations

  • Biocompatibility is device-level: ISO 10993-5 (cytotoxicity), ISO 10993-10 (sensitization) and ISO 10993-11 (systemic toxicity) are performed on the finished device — the resin supplier’s data is a starting point, but the device manufacturer must validate the finished device including all processing aids, colorants and surface treatments.
  • Processing affects biocompatibility: mold release agents, lubricants and cleaning solvents can leave residues that affect biocompatibility. The molding process should be validated to ensure that no processing aids remain on the part surface — or that any residues are removed by the cleaning process before sterilization.
  • Regulatory pathway is the device manufacturer’s responsibility: FDA 510(k), EU MDR and other regulatory submissions are the responsibility of the device manufacturer. The mold maker produces the part to the specification; the device manufacturer validates the biocompatibility, sterilization and regulatory compliance of the finished device.

    • What This Means for Your Quotation

    The quotation should specify the resin grade, the sterilization method and the biocompatibility requirements — so the mold design and molding process are optimized for the intended use. Medical-grade molds require additional documentation (material lot traceability, process validation records, dimensional reports) that should be itemized in the quotation. The cost of medical-grade molding is 20–50% higher than standard molding due to the documentation, validation and controlled environment requirements.

    Frequently Asked Questions

    Can any resin be used for medical devices?

    No — the resin must be a medical-grade formulation from the supplier, meaning the resin is produced under controlled conditions with documented lot traceability. Industrial-grade resins may contain additives, colorants or contaminants that are not suitable for medical applications. The resin supplier provides a certificate of conformance and biocompatibility data for the medical grade — the device manufacturer uses this data as part of the regulatory submission.

    What is the difference between EtO, gamma and autoclave sterilization?

    EtO (ethylene oxide) is a low-temperature gas sterilization (37–63°C) suitable for heat-sensitive resins like PC and ABS; gamma is a radiation sterilization suitable for most resins but can cause yellowing in PC; autoclave is a high-temperature steam sterilization (121°C) suitable for heat-resistant resins like PP and PEEK. The sterilization method is specified in the device’s regulatory submission — and the resin must be compatible with the specified method.

    Does the mold maker need to be qualified for medical work?

    The mold maker does not certify the device — the device manufacturer is responsible for the regulatory submission. However, the device manufacturer may require the mold maker to operate under a quality management system (such as ISO 13485 for medical devices) and to provide documentation of process validation, material traceability and dimensional inspection. The quotation should specify the documentation requirements so the mold maker can provide the necessary records.

    Key Takeaways

    1. Medical-grade resins (PC, PP, ABS, PEEK, silicone) must meet biocompatibility requirements (ISO 10993) and withstand the specified sterilization method — the resin selection depends on the application and the sterilization method.
    2. Biocompatibility is validated at the device level, not the resin level — the device manufacturer must validate the finished device including all processing aids and surface treatments.
    3. The quotation should specify the resin grade, sterilization method and documentation requirements — medical-grade molding costs 20–50% more due to validation, traceability and controlled environment requirements.

    Send aCatMould the part drawing with the resin specification, sterilization method and biocompatibility requirements, and the quotation documents the material traceability, process validation and dimensional inspection — so the mold and parts are produced to the medical device requirements.

    Sources
    ISO 10993-1 — Biological evaluation of medical devices
    FDA — medical device regulatory pathway and biocompatibility guidance
    Plastics Technology — medical-grade resin selection and sterilization compatibility

    Sources: Plastics Technology · Plastics Technology Online · Society of Plastics Engineers (SPE) · ThomasNet